Application of Circulating Tumor Cells and Circulating Free DNA from Peripheral Blood in the Prognosis of Advanced Gastric Cancer

Table 1

Basic information of enrolled patients.

	Items	Number (n)	Percentage (%)
Gender	M	40	88.89
	F	5	11.11
Age	>55	17	37.78
	≤55	28	62.22
Pathological typing	Adenocarcinoma	45	100
Degree of differentiattion	Low	16	35.55
	Moderate	16	35.55
	High	13	28.89
T staging	1–2	2	4.44
	3	26	57.78
	4	17	37.78
N staging	N0	0	0
	N+	45	100

M, male; F, female; T, tumor; and N, node.